The Office of Cancer Clinical Proteomics Research announced today its multi-institutional program to further the convergence of proteomics with genomics, or proteogenomics, to better understand the molecular basis of cancer and accelerate research in these areas by spreading research resources within the scientific community. Among these participating Proteogenomic Translational Research Centers (PTRCs) is the Lester and Sue Smith Breast Center, part of the NCI-designated Dan L Duncan Comprehensive Cancer Center at Baylor College of Medicine, the only site executing these tasks in the South.
Bringing centers together under CPTAC
The announcement of the PTRCs builds on the recently launched Proteome Characterization Centers (PCCs) and Proteogenomic Data Analysis Centers (PGDACs), which comprehensively characterize biospecimens and integrate/analyze resulting proteogenomic data to extrapolate cancer knowledge.
Baylor also has been awarded as a PGDAC site.
These three variations of proteogenomic centers of excellence (PCCs, PGDACs, and PTRCs) form the interdisciplinary pillars of the NCIs Clinical Proteomic Tumor Analysis Consortium (CPTAC), which centers on using the analysis of genomic and proteomic data to eventually help solve clinically relevant cancer questions, such as drug response and drug sensitivity.
This is an emerging method of collaboration, said Dr. Bing Zhang, professor in the Lester and Sue Smith Breast Center and the Department of Molecular and Human Genetics at Baylor. The CPTAC program encourages and allows multiple institutions to come together to share and contribute varied types of data, which is then studied and analyzed in a cooperative, mutually beneficial way.
Data generation and clinical implications through PTRCs
The Proteogenomic Translational Research Center at Baylor is jointly run by the Broad Institute and focuses on breast cancer specifically. The two institutions, and other PTRCs, will be working to generate and analyze proteogenomics data to further understand the behavior and functions of cancer cells in the advancement of precision oncology.
In the past, there has been an information gap between the data generation and the clinical implications, said Zhang, who is a McNair Scholar. The creation of the PTRCs addresses that gap, linking the molecular data with the clinical data.
The PTRCs will apply proteogenomics to questions of toxicity and resistance in clinical trials, using NCI-sponsored clinical trial samples.
Proteogenomics has great potential to unleash new insights in oncology. The combination of proteomic, transcriptomic, and genomic data can now reproducibly identify proteins in cancer genomes that were difficult or not possible to infer by genomics alone, said Dr. Henry Rodriguez, director of the Office of Cancer Clinical Proteomics Research of the National Cancer Institute, National Institutes of Health. We envision that PTRCs will collaborate with NCI-sponsored clinical trials to expand/deepen our knowledge of drug response and resistance, ultimately improving our understanding of the cancer and the tumor proteome.
As a Proteogenomic Translational Research Center, we are transitioning the proteogenomics technology and bioinformatics into clinical utility, giving us a deeper look at what the cancer cells are doing in patients, said Dr. Matthew Ellis, director of the Lester and Sue Smith Breast Center and co-PI for the PTRC at Baylor. The ability to access the clinical trial samples from the NCI will help us achieve big wins in cancer research in big populations, as opposed to smaller wins in more limited populations.
Data analysis through PGDACs
Whereas the Proteogenomic Translational Research Centers integrate clinical trial data and clinical implications, the Proteogenomic Data Analysis Centers focus on applying algorithms and computational tools to develop proteogenomic data to help the NCI expand its study of clinical trial and tumor samples beyond the existing colon, breast and ovarian cancers.
The establishment of the Proteogenomic Data Analysis Center at Baylor is a truly exciting development for our proteomics group, said Dr. Anna Malovannaya, assistant professor in biochemistry and molecular biology at Baylor. Cancer is a multifaceted disease, where personalized molecular medicine is not onlymuch needed, butalsoattainable, given the right diagnostic tools. It is now clear,in large part due to research performed in CPTAC laboratories,that integration of genomic and proteomic characterization, rather than either discipline alone, propels our ability to understand the underlying etiology of this complex disease.
As Baylor is both a Proteogenomic Data Analysis Center and Proteogenomic Translational Research Center site, the physical proximity of the facilities and research teams is beneficial to the project, encouraging integration among groups of scientists.
Proteogenomics and advancing precision oncology
The CPTAC program is the largest effort in the nation to advance precision medicine through proteogenomics, added Zhang. Through the PTRC and PGDAC sites, Ellis, Zhang and their team members will develop novel bioinformatics infrastructure for the integrative analysis of cancer genomic and proteomic data to advance cancer research and clinical care.
Proteogenomics will soon lead the discussion in cancer treatment, continued Zhang. We will analyze the genomic and proteomic data from individual tumors in order to determine what and how to target within the tumor, thereby allowing us to provide highly specialized care.
Proteogenomic analyses, where Zhangs group has done pioneering work, require momentous bioinformatics effort and innovation to help researchers sift through the wealth of next-generation data and pinpoint only the most critical, causal and targetable molecular events, explained Malovannaya, also the academic director for the Mass Spectrometry Proteomics Core. We are looking forward to being a part of CPTAC through these new consortium centers, and to fully utilizing Baylors proteomics, informatics and clinical expertise in transforming cancer research, Malovannaya said.
Its an entirely new way of looking at clinical specimen to drive therapies, said Ellis, who also is a McNair Scholar. Not only are these centers executing very exciting work, but Baylor is the only site involved in this project our region, with speaks to its strengths in both clinical and bioinformatics areas.
Continued here:
- June 11th At Westport, CT: Federal Red Flags, HIPAA Security Rules and Fraud Prevention - November 7th, 2009 [November 7th, 2009]
- Do not learn Dvorak! - November 7th, 2009 [November 7th, 2009]
- You Can’t Solve Problems By Making It Illegal To Have The Problem - November 7th, 2009 [November 7th, 2009]
- A Force Fix for Healthcare - November 7th, 2009 [November 7th, 2009]
- Yahble, HIT, Bubblecon, BIZDEV!, Solid State - November 7th, 2009 [November 7th, 2009]
- 15 things that suck about the Palm Pre - November 7th, 2009 [November 7th, 2009]
- What an Indie Genomics Lab Looks Like - November 7th, 2009 [November 7th, 2009]
- Practice Fusion: Class D Felony? - February 26th, 2010 [February 26th, 2010]
- Practice Fusion Responds - March 7th, 2010 [March 7th, 2010]
- Practice Fusion: Do the math: $44,000 is a LIE - March 10th, 2010 [March 10th, 2010]
- How Much Until Doctors Approve of 23andMe? - March 10th, 2010 [March 10th, 2010]
- Biochemicals as Media, Not Methods - March 10th, 2010 [March 10th, 2010]
- More Practice Fusion Reality Distortion - March 10th, 2010 [March 10th, 2010]
- Same Test Results: 23andMe is Myriad is BRCA is Medicine - March 12th, 2010 [March 12th, 2010]
- BRCA is 23andMe is Myriad is Medicine - March 13th, 2010 [March 13th, 2010]
- Getting Serious About Genomics as Common Medical Practice - March 15th, 2010 [March 15th, 2010]
- The New John Mackey of Genetics: Linda Avey? - March 15th, 2010 [March 15th, 2010]
- Keep the Medical, Well, Medical - March 16th, 2010 [March 16th, 2010]
- If 23andMe shuts down, it won’t be for some mundane reason like the bills weren’t paid - March 16th, 2010 [March 16th, 2010]
- If I Run A Medical Practice, How Do I Use A 23andMe? - March 17th, 2010 [March 17th, 2010]
- 23andMe Contract in Bad Faith - March 19th, 2010 [March 19th, 2010]
- Doctors CANNOT Use 23andMe Due To 23andMe’s Bad Faith Contract - March 20th, 2010 [March 20th, 2010]
- Pathway Compared to 23andMe and Navigenics - March 22nd, 2010 [March 22nd, 2010]
- There’s a Word for “Views Differ” When One View Is The State - March 24th, 2010 [March 24th, 2010]
- Association for Molecular Pathology, et al. v. USPTO, et al. – Opinion - March 29th, 2010 [March 29th, 2010]
- Birth of a Super Villain - April 3rd, 2010 [April 3rd, 2010]
- “Medical Products” like 23andMe must not become the new “Financial Products” - April 4th, 2010 [April 4th, 2010]
- How I Would Apply Genomic Technology In Clinical Use Today - April 5th, 2010 [April 5th, 2010]
- Gmail Enterprise: World’s Best EMR - April 6th, 2010 [April 6th, 2010]
- Brief Primer on Health Law Compliance - April 9th, 2010 [April 9th, 2010]
- Spoiler: You ARE the “Valids” - April 9th, 2010 [April 9th, 2010]
- Rachel Lehmann-Haupt Line by Line Take Down - April 9th, 2010 [April 9th, 2010]
- Is Medicare Bankrupt? What the Hell Is Going On? - April 17th, 2010 [April 17th, 2010]
- The Big Shuffle: Medicare Cuts Rates by 21.3% (but not “technically”) - April 17th, 2010 [April 17th, 2010]
- “Tech Hiring Binge” == “Fear for Your Job, Nerds” - April 18th, 2010 [April 18th, 2010]
- How Bad is Bad? $.20 on the Private Medical Insurance Dollar - April 20th, 2010 [April 20th, 2010]
- Update: How Bad is Bad? It Used to Be $.45 on the Medical Insurance Dollar - April 20th, 2010 [April 20th, 2010]
- World’s Best “EMR” for $1000: Google Spreadsheets + iPad - April 21st, 2010 [April 21st, 2010]
- Don’t Insult Me with your “AOL Keyword” Strategy, Google Health - April 21st, 2010 [April 21st, 2010]
- How to Play LAWGAMES - April 23rd, 2010 [April 23rd, 2010]
- Top 4 Predatory Schemes Encroaching on American Medicine: Part 1 - April 25th, 2010 [April 25th, 2010]
- What’s the Big Deal About iPads? - April 27th, 2010 [April 27th, 2010]
- Got Google Android for Google I/O - April 27th, 2010 [April 27th, 2010]
- Google Enterprise meets HIPAA and HITECH Compliant Laws - April 29th, 2010 [April 29th, 2010]
- Pixels of Accuracy CHALENGE: Diagnostic Medical Imaging - April 29th, 2010 [April 29th, 2010]
- 23andMe Launder AlioGenetics Doesn’t Even Bother to Remove 23andMe Logo - April 30th, 2010 [April 30th, 2010]
- Anthem of CT Denies $600 Until “Subscriber Responds to our Coordination of Benefits Questionnaire” - May 1st, 2010 [May 1st, 2010]
- Apple And Google Team Up To Launch Revolutionary Mobile Health System - May 1st, 2010 [May 1st, 2010]
- Funny Pictures from This Year Building the Medical Practice - May 6th, 2010 [May 6th, 2010]
- Remote Medical Video Monitoring on iPad and iPhone - May 7th, 2010 [May 7th, 2010]
- Google Calendar Overhead Waiting Room Display - May 7th, 2010 [May 7th, 2010]
- Various Whiteboards on Solid State Medical Operations - May 7th, 2010 [May 7th, 2010]
- The Raw Facts about Counsyl - May 7th, 2010 [May 7th, 2010]
- Brawndo: Still Mutilating Thirst, Still Not Yet Sold at the Stop-n-Shop Pharmacy - May 9th, 2010 [May 9th, 2010]
- Video: Google Enterprise to Outsource Medical Administration - May 9th, 2010 [May 9th, 2010]
- Gattaca: “The Matrix” of Genomics - May 11th, 2010 [May 11th, 2010]
- 23andMe Now Diagnoses Fatal Tay-Sachs Disease - May 12th, 2010 [May 12th, 2010]
- Why Was Pathway Targeted for FDA Enforcement and Not 23andMe? - May 15th, 2010 [May 15th, 2010]
- John Dolan on Aging and the Horrifying Conclusion of GWAS - May 16th, 2010 [May 16th, 2010]
- Sam R. Riley Wants To Tell You About Practice Fusion - May 17th, 2010 [May 17th, 2010]
- Response to “Genomic Medicine: Lost” - May 19th, 2010 [May 19th, 2010]
- Death And Taxes: CMS to IRS - May 19th, 2010 [May 19th, 2010]
- Please Stop Antagonizing the AMA - May 26th, 2010 [May 26th, 2010]
- Dan Vorhaus, Attorney At Law, Legally Advises Medical Doctors Can Use 23andMe To Provide Medical Advice - May 28th, 2010 [May 28th, 2010]
- Singularity Summit 2010 in San Francisco to Explore Intelligence Augmentation - June 7th, 2010 [June 7th, 2010]
- OpenPCR: DNA amplification for anyone - June 10th, 2010 [June 10th, 2010]
- FDA sends letters to 5 genetic testing companies - June 11th, 2010 [June 11th, 2010]
- Amazon And The NIH Team Up To Put Human Genome In The Cloud - March 31st, 2012 [March 31st, 2012]
- ReproSource Comments on New Study Linking Infertility to Genetics - April 25th, 2012 [April 25th, 2012]
- Genetics 101 Part 1: What are genes? - Video - April 30th, 2012 [April 30th, 2012]
- Red Ice Radio - David Icke - Hour 1 - The Manipulation of Humanity - Video - April 30th, 2012 [April 30th, 2012]
- Genetics Part 5: Human Genetic Disorders - Video - April 30th, 2012 [April 30th, 2012]
- C2CAM - The Nephilim, Genetic Manipulation - April 30th, 2012 [April 30th, 2012]
- Human Nature talk with Robert Sapolsky, Gabor Mate, James Gilligan, Richard Wilkinson - Video - April 30th, 2012 [April 30th, 2012]
- Human Genetic Diseases - Video - April 30th, 2012 [April 30th, 2012]
- Alien Scientist on Genetics, Implants - April 30th, 2012 [April 30th, 2012]
- Research and Markets: Genetics, 6th Edition International Student Version Continues To Educate Today's Students for ... - May 4th, 2012 [May 4th, 2012]
- Myriad Genetics to Present at the Bank of America Merrill Lynch 2012 Health Care Conference - May 4th, 2012 [May 4th, 2012]
- Genetics may explain some people's dislike of meat - May 4th, 2012 [May 4th, 2012]
- 'Blond Genes' May Vary Around the World - May 4th, 2012 [May 4th, 2012]